International โ€บ UK ยท Last reviewed 2026-05-16

United Kingdom โ€” Tavistock GIDS

Summary

The Gender Identity Development Service (GIDS) was established in 1989 by Domenico Di Ceglie at St George's Hospital in London and later moved to the Tavistock and Portman NHS Foundation Trust; it closed on 31 March 2024. Before 2009 GIDS saw fewer than 50 children a year; in 2021/22 it received roughly 5,000 referrals, a figure that according to the Cass Review may include double counting (source). After the final Cass report, NHS England stated that puberty blockers are no longer routinely available in NHS gender services for children and young people (source).

1. History of GIDS

YearEvent
1989Founding of GIDS, St George's Hospital
2011Start of "Early Intervention Study" (GnRHa under 16)
2014Puberty blockers also prescribed outside the early intervention study; referrals begin to rise exponentially
2020Bell v Tavistock: High Court ruling (December); Cass Review commissioned by NHS England (autumn)
2021Court of Appeal finds for the clinic in Bell v Tavistock (17 September)
2022Cass interim report; announcement of closure
2024Closure of GIDS; opening of regional hubs

2. Referral figures

Before 2009 GIDS saw fewer than 50 children per year. From 2014 referrals grew exponentially, to roughly 5,000 in 2021/22 (a figure that may include double counting, according to the Cass Review), with a majority of birth-registered females presenting in their early teens (source).1

3. Replication studies of the Dutch Protocol

Two studies from the GIDS looked at the outcomes of puberty suppression: Costa et al. (2015, 201 adolescents) and Carmichael et al. (2021, 44 participants, the "early intervention study"). Costa et al. found improved psychosocial functioning after psychological support and, to a greater extent, after 12 months of puberty suppression (source). Carmichael et al. did not find the improvement in mental health that the original Dutch study found (source); in that study 98 percent (43 of 44) went on to hormones (source). See /studies/replication-attempts/.

4. Cass Review and NHS policy

The Cass Review (commissioned in autumn 2020; interim report 2022; final report 10 April 2024) called the field "an area of remarkably weak evidence" and advised in July 2023 that puberty blockers should only be offered within a research protocol (source). After the final report NHS England stated that puberty blockers are no longer routinely available in NHS gender services for children and young people (source).2 For masculinising or feminising hormones from age 16 the Cass Review advises "extreme caution" (recommendation 8).

5. Bell v Tavistock

The case Bell v Tavistock was a judicial review, brought by Keira Bell, of the practice of the former GIDS with puberty blockers for minors; the High Court ruled in December 2020 and the Court of Appeal found for the clinic on 17 September 2021 (source). See /debate/legal-cases/.

See also

Footnotes

  1. Cass H. Independent review of gender identity services for children and young people: final report. April 2024.
  2. NHS England. NHS England's response to the final report of the independent review of gender identity services for children and young people. 10 April 2024.